Log in

Relevant bibliographies by topics / Combination / Journal articles

Journal articles on the topic 'Combination'

To see the other types of publications on this topic, follow the link: Combination.

Author: Grafiati

Published: 4 June 2021

Last updated: 30 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Combination.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Kotovskaya, Yu V., N. К. Runikhina, and V. S. Ostapenko. "COMBINATION ANTIHYPERTENSION THERAPY: THE “UNDERRESEARCHED” COMBINATIONS." Russian Journal of Cardiology, no. 5 (January 1, 2017): 132–39. http://dx.doi.org/10.15829/1560-4071-2017-5-132-139.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cheng, Lan, and Xuguang Simon Sheng. "Combination of “combinations of p values”." Empirical Economics 53, no. 1 (February 11, 2017): 329–50. http://dx.doi.org/10.1007/s00181-017-1230-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

Ali, Naseem, Arzoo Shamoon, Neelesh Yadav, and Tanuj Sharma. "Peptide Combination Generator: a Tool for Generating Peptide Combinations." ACS Omega 5, no. 11 (March 16, 2020): 5781–83. http://dx.doi.org/10.1021/acsomega.9b03848.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

TANOUE, Masahiro. "Good Combination and Bad Combination." JOURNAL OF JAPAN SOCIETY OF HYDROLOGY AND WATER RESOURCES 33, no. 4 (July 5, 2020): 176–77. http://dx.doi.org/10.3178/jjshwr.33.176.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

Burgess, Darren J. "Combination screens for combination therapies." Nature Reviews Genetics 17, no. 6 (April 12, 2016): 313. http://dx.doi.org/10.1038/nrg.2016.52.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

Gilad, Yosi, Gary Gellerman, David M. Lonard, and Bert W. O’Malley. "Drug Combination in Cancer Treatment—From Cocktails to Conjugated Combinations." Cancers 13, no. 4 (February 7, 2021): 669. http://dx.doi.org/10.3390/cancers13040669.

Full text

Abstract:

It is well recognized today that anticancer drugs often are most effective when used in combination. However, the establishment of chemotherapy as key modality in clinical oncology began with sporadic discoveries of chemicals that showed antiproliferative properties and which as a first attempt were used as single agents. In this review we describe the development of chemotherapy from its origins as a single drug treatment with cytotoxic agents to polydrug therapy that includes targeted drugs. We discuss the limitations of the first chemotherapeutic drugs as a motivation for the establishment of combined drug treatment as standard practice in spite of concerns about frequent severe, dose limiting toxicities. Next, we introduce the development of targeted treatment as a concept for advancement within the broader field of small-molecule drug combination therapy in cancer and its accelerating progress that was boosted by recent scientific and technological progresses. Finally, we describe an alternative strategy of drug combinations using drug-conjugates for selective delivery of cytotoxic drugs to tumor cells that potentiates future improvement of drug combinations in cancer treatment. Overall, in this review we outline the development of chemotherapy from a pharmacological perspective, from its early stages to modern concepts of using targeted therapies for combinational treatment.

APA, Harvard, Vancouver, ISO, and other styles

7

Souček, Miroslav, Hana Nechutová, Jan Novák, and Ivan Řiháček. "Combination therapy for hypertension with a focus on fixed combinations." Interní medicína pro praxi 19, no. 2 (April 1, 2017): 58–65. http://dx.doi.org/10.36290/int.2017.011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Park, Kinam. "True combination therapy using synergistic drug combination." Journal of Controlled Release 187 (August 2014): 198. http://dx.doi.org/10.1016/j.jconrel.2014.06.034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

9

Mahammatov, Abdumannon, Azam Abdurakhimov, and Mingjigit Kholbekov. "Combination Of Music And Physical Education." American Journal of Social Science and Education Innovations 03, no. 03 (March 6, 2021): 6–15. http://dx.doi.org/10.37547/volume03issue03-02.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

S.Shantha, S. Shantha. "Dhana Yoga- The Combination For Prosperity." International Journal of Scientific Research 3, no. 4 (June 1, 2012): 12–14. http://dx.doi.org/10.15373/22778179/apr2014/6.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Shelton, Richard C. "The return of fixed combinations in psychiatry: fluoxetine and olanzapine combination." Therapeutics and Clinical Risk Management 2, no. 2 (April 2006): 187–91. http://dx.doi.org/10.2147/tcrm.2006.2.2.187.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Kucukosmanoglu, Asli, Silvia Scoarta, Thomas Wijnands, George Kanev, Bart Westerman, Bert Kiewit, David Noske, and Tom Wurdinger. "Abstract 6312: The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies." Cancer Research 82, no. 12_Supplement (June 15, 2022): 6312. http://dx.doi.org/10.1158/1538-7445.am2022-6312.

Full text

Abstract:

Abstract The current gold-standard of estimating adverse events of a drug are clinical trials. However, these trials fail to represent real-life practice where patients have additional diseases (comorbidities) and commonly use numerous drugs when entering the clinic. Therefore, there is a rise of interest in combinational therapies, also because effective combinations are expected to prevent therapy resistance. At this moment it is not feasible to predict the adverse events of new combination therapies due to lack of available information both from a dimensionality (i.e., number of adverse events recorded per patient) as well as from a patient-number perspective. When available, this information allows to choose combinational therapies with acceptable adverse events. In this study we developed a preliminary method to predict adverse events of drug combinations in order to select combinations with a mild adverse event profile. We used the FAERS, an FDA post-marketing adverse events registry as data source containing 15 million adverse-event records. First, we developed a method to visualize the adverse events profiles of monotherapy and combination therapy using dimension reduction to accurately represent the relation between adverse events over many patients. These adverse-event profiles are then fed to a convolutional neural network (CNN) to generate an explainable prediction-model for adverse events occurring in combination therapies. The CNN trained on monotherapy is able to learn from the data and recognize adverse event patterns. The learned pattern information, as stored in the so-called latent space, can be converted back onto the original adverse event profiles. This showed a high similarity to the original data, also for unseen combination therapy effects. Furthermore, a t-SNE analysis on the latent space of the CNN is able to separate additive and synergistic adverse event patterns in combination therapy. Our CNN model can successfully learn complex adverse-event patterns for single drugs and their combinations, which are all encoded in the latent space. The developed method is therefore applicable to determine the combinatorial effects of highly complex adverse event profiles. Citation Format: Asli Kucukosmanoglu, Silvia Scoarta, Thomas Wijnands, George Kanev, Bart Westerman, Bert Kiewit, David Noske, Tom Wurdinger. The adverse events atlas, towards a strategy to predict synergistic adverse events of combination therapies [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2022; 2022 Apr 8-13. Philadelphia (PA): AACR; Cancer Res 2022;82(12_Suppl):Abstract nr 6312.

APA, Harvard, Vancouver, ISO, and other styles

13

Martin, Des. "Combination counselling." Southern African Journal of HIV Medicine 4, no. 2 (July 14, 2003): 5. http://dx.doi.org/10.4102/sajhivmed.v4i2.542.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Brzeziński, Krzysztof. "Opioid combination." Współczesna Onkologia 6 (2011): 415–17. http://dx.doi.org/10.5114/wo.2011.26449.

Full text

APA, Harvard, Vancouver, ISO, and other styles

15

Skibinski, DavidA G., BarbaraC Baudner, Manmohan Singh, and DerekT O′Hagan. "Combination vaccines." Journal of Global Infectious Diseases 3, no. 1 (2011): 63. http://dx.doi.org/10.4103/0974-777x.77298.

Full text

APA, Harvard, Vancouver, ISO, and other styles

16

Manson, Richard A. "Combination hook." Journal of Pediatric Ophthalmology & Strabismus 33, no. 2 (March 1996): 134. http://dx.doi.org/10.3928/0191-3913-19960301-18.

Full text

APA, Harvard, Vancouver, ISO, and other styles

17

Rajendran, Sridharan, and FNU Baburajan. "Combination Syndrome." International Journal of Prosthodontics and Restorative Dentistry 2, no. 4 (2012): 156–60. http://dx.doi.org/10.5005/jp-journals-10019-1066.

Full text

Abstract:

ABSTRACT Combination syndrome (CS) is a dental condition that is commonly seen in patients with a completely edentulous maxilla and partially edentulous mandible with preserved anterior teeth. This syndrome consists of severe anterior maxillary resorption combined with hypertrophic and atrophic changes in different quadrants of maxilla and mandible. This makes it a challenging condition in dentistry that requires significant experience along with advanced restorative and surgical skills. The causes of maxillary bone resorption and ways to correct it are discussed in this article. Conventional treatment with full upper and partial lower dentures for the CS patients is not always adequate or satisfying for patients and it often requires multiple remakes due to continuing bone resorption. Dental implant rehabilitation challenges conventional treatment with bone-anchoring techniques to provide improved retention and stability for implant-retained and supported prostheses. This article presents a successful implant treatment of the partially edentulous maxilla in CS patient. The necessity of a multidisciplinary approach for early prevention and treatment of this complex condition is emphasized. This article illustrates a review of the changes and difficulties faced when treated with conventional approach which can be overcome with the aid of implant-supported prosthesis. How to cite this article Rajendran S, Baburajan. Combination Syndrome. Int J Prosthodont Restor Dent 2012;2(4):156-160.

APA, Harvard, Vancouver, ISO, and other styles

18

Poutanen, Tuomo. "Load Combination." IABSE Symposium Report 100, no. 5 (June 1, 2013): 260–67. http://dx.doi.org/10.2749/222137813807018854.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

Zink, Brian. "Bad Combination." Academic Emergency Medicine 19, no. 10 (September 20, 2012): 1216. http://dx.doi.org/10.1111/j.1553-2712.2012.01444.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

Edwards, Michael R., Malcolm W. Johnson, and Sebastian L. Johnston. "Combination Therapy." American Journal of Respiratory Cell and Molecular Biology 34, no. 5 (May 2006): 616–24. http://dx.doi.org/10.1165/rcmb.2005-0385oc.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Duncan, Robert. "Deadly combination." Nature 527, no. 7577 (November 2015): 172–73. http://dx.doi.org/10.1038/527172a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

Kaufmann, Stefan H. E. "Deadly combination." Nature 453, no. 7193 (May 2008): 295–96. http://dx.doi.org/10.1038/453295a.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Gever, Marcy Portnoff. "Combination drugs…" Nursing 36, no. 7 (July 2006): 63. http://dx.doi.org/10.1097/00152193-200607000-00050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

24

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 36, no. 9 (September 2006): 70. http://dx.doi.org/10.1097/00152193-200609000-00049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

25

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 36, no. 10 (October 2006): 77. http://dx.doi.org/10.1097/00152193-200610000-00050.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 37, no. 1 (January 2007): 71. http://dx.doi.org/10.1097/00152193-200701000-00051.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 37, no. 2 (February 2007): 71. http://dx.doi.org/10.1097/00152193-200702000-00049.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 35, no. 8 (August 2005): 76. http://dx.doi.org/10.1097/00152193-200508000-00057.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 35, no. 10 (October 2005): 73. http://dx.doi.org/10.1097/00152193-200510000-00053.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

GEVER, MARCY PORTNOFF. "Combination drugs …" Nursing 36, no. 1 (January 2006): 25. http://dx.doi.org/10.1097/00152193-200601000-00017.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 36, no. 2 (February 2006): 69. http://dx.doi.org/10.1097/00152193-200602000-00054.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

GEVER, MARCY PORTNOFF. "Combination drugs…" Nursing 36, no. 4 (April 2006): 67. http://dx.doi.org/10.1097/00152193-200604000-00052.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Denke, Margo A. "Combination Therapy." Journal of Managed Care Pharmacy 9, no. 1 Supp A (January 2003): 17–19. http://dx.doi.org/10.18553/jmcp.2003.9.s1.17.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Williams, Ruth. "Winning combination." Nursing Management 20, no. 4 (July 2013): 37. http://dx.doi.org/10.7748/nm2013.07.20.4.37.s22.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Novak, Kristine. "Killer combination." Nature Reviews Cancer 3, no. 5 (May 2003): 318. http://dx.doi.org/10.1038/nrc1088.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Liu, Bin, Raju Rangaswami, and Zoran Dimitrijevic. "Stream combination." ACM SIGBED Review 3, no. 1 (January 2006): 23–28. http://dx.doi.org/10.1145/1279711.1279717.

Full text

APA, Harvard, Vancouver, ISO, and other styles

37

Rennels, Margaret B. "COMBINATION VACCINES." Pediatric Infectious Disease Journal 21, no. 3 (March 2002): 255–57. http://dx.doi.org/10.1097/00006454-200203000-00018.

Full text

APA, Harvard, Vancouver, ISO, and other styles

38

Habib, Ashraf S., and Tong J. Gan. "Combination Antiemetics." International Anesthesiology Clinics 41, no. 4 (2003): 119–44. http://dx.doi.org/10.1097/00004311-200341040-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

39

Yuan-Dong, Sun, Zhang Hao, Xu Hui-Rong, Liu Jing-Zhou, Wu Hui-Yong, Han Jian-Jun, and Jin-Ming Yu. "Combination therapy." Medicine 98, no. 49 (December 2019): e18030. http://dx.doi.org/10.1097/md.0000000000018030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

40

Roenigk, Henry H. "Combination resurfacing." Dermatologic Therapy 13, no. 2 (April 2000): 215–22. http://dx.doi.org/10.1046/j.1529-8019.2000.00016.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

van der Lippe, Tanja, Annet Jager, and Yvonne Kops. "Combination Pressure." Acta Sociologica 49, no. 3 (September 2006): 303–19. http://dx.doi.org/10.1177/0001699306067711.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Wade, Charles E., and René M. Sauer. "Combination Therapeutics." Shock 35, no. 6 (June 2011): 639–40. http://dx.doi.org/10.1097/shk.0b013e3182115e1b.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

Hessel, Luc, John Vose, and Aventis Pasteur. "Combination vaccines." Journal of Pediatrics 138, no. 4 (April 2001): 613. http://dx.doi.org/10.1067/mpd.2001.113782.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

Ingemarsson, Ingemar. "Combination therapy." BJOG: An International Journal of Obstetrics & Gynaecology 112 (February 16, 2005): 89–93. http://dx.doi.org/10.1111/j.1471-0528.2005.00593.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

Hadden, J. W., and K. Masek. "Combination immunotherapy." International Immunopharmacology 3, no. 8 (August 2003): 1049–50. http://dx.doi.org/10.1016/s1567-5769(03)00018-3.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Ellis, Ronald W., and R. Gordon Douglas. "Combination Vaccines." International Journal of Technology Assessment in Health Care 10, no. 1 (1994): 185–92. http://dx.doi.org/10.1017/s0266462300014112.

Full text

Abstract:

AbstractThe availability of new vaccines for pediatric use provides an unprecedented opportunity to prevent serious infectious diseases and their associated morbidity and mortality. However, each new product entails the need for additional injections that could become so numerous as to discourage the administration of new vaccines. This challenge can be overcome by mixing individual vaccines before delivery such that multiple vaccines are administered as single combination vaccines. Technical, clinical, manufacturing, regulatory and marketing issues relative to combination vaccines in general are the major challenges for ongoing and future development.

APA, Harvard, Vancouver, ISO, and other styles

47

EDWARDS, KATHRYN M., and MICHAEL D. DECKER. "Combination vaccines." Pediatric Infectious Disease Journal 13, no. 5 (May 1994): 345–47. http://dx.doi.org/10.1097/00006454-199405000-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Carlson, Robert. "Combination therapies." Oncology Times 2, no. 7 (July 2005): 14. http://dx.doi.org/10.1097/01434893-200507000-00007.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Kumar, A., and M. G. Rossmann. "Phase Combination." Acta Crystallographica Section D Biological Crystallography 52, no. 3 (May 1, 1996): 518–20. http://dx.doi.org/10.1107/s0907444996000467.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

GEVER, MARCY PORTNOFF. "Combination drugs..." Nursing 36, no. 5 (May 2006): 69. http://dx.doi.org/10.1097/01.nurse.0000393395.87573.93.

Full text

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!